APURES CO., LTD.

Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.

149300 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 평택시 청북읍 한산길 44, 평택시
Website:: https://www.apures.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

APURES CO., LTD. is a biotechnology company that provides comprehensive R&D solutions for the pharmaceutical and life sciences industries. The company's core business is centered on its proprietary 'MICROPIG,' an internationally registered miniature pig model anatomically and physiologically similar to humans, which serves as a platform for advanced medical research. APURES offers a range of products and services, including standardized R&D resources (organs, tissues, primary cells), non-clinical Contract Research Organization (CRO) services for drug development, and bio-materials for regenerative medicine and xenotransplantation. Building on its expertise in transgenic models, the company is also strategically expanding into the development of proprietary gene therapies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for APURES CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all APURES CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for APURES CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Mendus Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.	Sweden	IMMU
Metavista3D, Inc. Develops AI-driven, glasses-free 3D holographic displays for the defense sector.	United States of America	N/A
MicroAd,Inc. Data-driven marketing tech providing DSP and SSP solutions for digital advertising.	Japan	9553
Microwave Chemical Co., Ltd. Innovating chemical and metal processing with an eco-friendly microwave platform.	Japan	9227
Mitsubishi Research Institute, Inc. A think tank providing research, consulting, and ICT solutions to public & private sectors.	Japan	3636
Modalis Therapeutics Corporation Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.	Japan	4883
Model Solution Co., Ltd. One-stop prototyping & low-volume production for IT, electronics, and medical hardware.	South Korea	417970
Modus Therapeutics Holding AB Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.	Sweden	MODTX
Molecure S.A. Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.	Poland	MOC
Mural Oncology PLC Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.		N/A